These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7700394)

  • 21. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP; Galinowski A; Lehert P; Lemonnier F; Lôo H
    Encephale; 1993; 19(4):333-40. PubMed ID: 8275921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
    Rogóz Z; Dziedzicka-Wasylewska M; Daniel WA; Wójcikowski J; Dudek D; Wróbel A; Zieba A
    Pol J Pharmacol; 2004; 56(6):735-42. PubMed ID: 15662086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of personality factors in depression].
    Quitkin FM
    Encephale; 1993 Aug; 19 Spec No 3():491-2. PubMed ID: 8299548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression.
    Frank E; Grochocinski VJ; Spanier CA; Buysse DJ; Cherry CR; Houck PR; Stapf DM; Kupfer DJ
    J Clin Psychiatry; 2000 Jan; 61(1):51-7. PubMed ID: 10695647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA; Wróbel A; Dudek D; Zieba A
    Pol J Pharmacol; 2004; 56(6):849-55. PubMed ID: 15662100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity.
    Inoue T; Nakagawa S; Kitaichi Y; Izumi T; Tanaka T; Masui T; Kusumi I; Denda K; Koyama T
    J Affect Disord; 2006 Oct; 95(1-3):61-7. PubMed ID: 16797078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy refractory depression].
    Hatzinger M; Holsboer-Trachsler E
    Wien Med Wochenschr; 1999; 149(18):511-4. PubMed ID: 10637955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant augmentation with lithium.
    Manning JS; Connor PD
    J Fam Pract; 1994 Oct; 39(4):379-83. PubMed ID: 7931118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stabilization of high blood pressure with tricyclic antidepressants and lithium combinations in hypertensive patients.
    Zachariah PK; Rosenbaum AH
    Mayo Clin Proc; 1982 Oct; 57(10):625-8. PubMed ID: 7121068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [L-tryptophan plasma levels in treatment resistant depressive states].
    Perret G; Hilleret H; Widmer JR; Bovier P
    Rev Med Suisse Romande; 2000 Feb; 120(2):153-7. PubMed ID: 10748702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A lithium-tricyclic combination for treatment of depression.
    Pande AD; Max P
    Am J Psychiatry; 1985 Oct; 142(10):1228-9. PubMed ID: 3929631
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antidepressive prevention with lithium salts: possible interaction with occupational exposure to nephrotoxic substances].
    Zerbi F; Biscaldi GP; Rivolta GL; Pugliese F; Tosca P
    G Ital Med Lav; 1985; 7(2-3):107-9. PubMed ID: 3939219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse of depression during continuation treatment: three clinical vignettes.
    Nasr SJ; Gaviria M; Grupp M; Rodgers P
    J Clin Psychopharmacol; 1983 Feb; 3(1):32-4. PubMed ID: 6833521
    [No Abstract]   [Full Text] [Related]  

  • 38. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders.
    Dé Montigny C; Grunberg F; Mayer A; Deschenes JP
    Br J Psychiatry; 1981 Mar; 138():252-6. PubMed ID: 7272619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Critical evaluation of the value and limitations of plasma assays of imipramine derivatives for therapeutic monitoring].
    Bonin B; Vandel B; Vandel S; Volmat R
    Therapie; 1986; 41(2):115-8. PubMed ID: 3726782
    [No Abstract]   [Full Text] [Related]  

  • 40. Tryptophan and tyrosine availability: relation to clinical response to antidepressive pharmacotherapy.
    Møller SE; Larsen OB
    Adv Biochem Psychopharmacol; 1984; 39():319-26. PubMed ID: 6380228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.